Qingguo Xie Selected Research

Qingguo Xie Research Topics

5	Alzheimer Disease (Alzheimer's Disease) 03/2023 - 11/2017
5	Neoplasms (Cancer) 04/2014 - 01/2012
2	Insulin Resistance 03/2023 - 06/2017
2	Cholangiocarcinoma 03/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2013
2	Inflammation (Inflammations) 01/2021 - 06/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Fatty Liver 06/2017 - 04/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Tauopathies 01/2021
1	Gliosis 01/2021
1	Sleep Deprivation 01/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 10/2020
1	Glucose Intolerance 10/2020
1	Cognitive Dysfunction 01/2020
1	Non-alcoholic Fatty Liver Disease 06/2017
1	Ischemia 04/2014
1	Infarction (Infarctions) 04/2014

4	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 10/2020
3	IntegrinsIBA 04/2014 - 12/2012
2	Insulin (Novolin)FDA Link 03/2023 - 10/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 11/2017
2	Peptides (Polypeptides)IBA 04/2017 - 12/2012
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2014 - 01/2014
1	EnzymesIBA 03/2023
1	InflammasomesIBA 03/2023
1	Proteins (Proteins, Gene)FDA Link 03/2023
1	NLR ProteinsIBA 03/2023
1	anlotinibIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 04/2021
1	Selenoproteins (Selenoprotein)IBA 10/2020
1	Glycoproteins (Glycoprotein)IBA 10/2020
1	VanadiumIBA 01/2020
1	CateninsIBA 11/2017
1	SeleniumIBA 11/2017
1	Selenic AcidIBA 11/2017
1	mouse RECS1 proteinIBA 06/2017
1	arginyl-glycyl-aspartic acidIBA 04/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Albumin-Bound Paclitaxel FDA Link 01/2014
1	alfatide IIIBA 05/2013
1	antibiotic K 4 (K 4)IBA 01/2012

3	Therapeutics 01/2023 - 05/2013
2	Hepatectomy 03/2022 - 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2023
1	Adjuvant Chemotherapy 03/2022
1	Precision Medicine 01/2022